Daniel F. Gaddy, Ph.D. - Publications

Affiliations: 
2006 Wake Forest University, Winston-Salem, NC, United States 
Area:
Microbiology Biology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Geretti E, Leonard SC, Dumont N, Lee H, Zheng J, De Souza R, Gaddy DF, Espelin CW, Jaffray DA, Moyo V, Nielsen UB, Wickham TJ, Hendriks BS. Cyclophosphamide-mediated tumor priming for enhanced delivery and anti-tumor activity of HER2-targeted liposomal doxorubicin (MM-302). Molecular Cancer Therapeutics. PMID 26162690 DOI: 10.1158/1535-7163.MCT-15-0314  0.96
2015 Gaddy DF, Lee H, Zheng J, Jaffray DA, Wickham TJ, Hendriks BS. Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates. Ejnmmi Research. 5: 24. PMID 25918676 DOI: 10.1186/s13550-015-0096-0  0.96
2014 Tilstra JS, Gaddy DF, Zhao J, Davé SH, Niedernhofer LJ, Plevy SE, Robbins PD. Pharmacologic IKK/NF-κB inhibition causes antigen presenting cells to undergo TNFα dependent ROS-mediated programmed cell death. Scientific Reports. 4: 3631. PMID 24406986 DOI: 10.1038/srep03631  0.96
2013 Hendriks BS, Klinz SG, Reynolds JG, Espelin CW, Gaddy DF, Wickham TJ. Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effect. Molecular Cancer Therapeutics. 12: 1816-28. PMID 23723124 DOI: 10.1158/1535-7163.MCT-13-0180  0.96
2010 Gaddy DF, Riedel MJ, Pejawar-Gaddy S, Kieffer TJ, Robbins PD. In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes. Diabetes. 59: 3108-16. PMID 20841608 DOI: 10.2337/db09-1886  0.96
2010 Pejawar-Gaddy S, Rajawat Y, Hilioti Z, Xue J, Gaddy DF, Finn OJ, Viscidi RP, Bossis I. Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles. Cancer Immunology, Immunotherapy : Cii. 59: 1685-96. PMID 20652244 DOI: 10.1007/s00262-010-0895-0  0.96
2007 Gaddy DF, Lyles DS. Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx Journal of Virology. 81: 2792-2804. PMID 17192316 DOI: 10.1128/JVI.01760-06  0.96
2005 Gaddy DF, Lyles DS. Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways Journal of Virology. 79: 4170-4179. PMID 15767418 DOI: 10.1128/JVI.79.7.4170-4179.2005  0.96
Show low-probability matches.